Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded the term Primary biliary cholangitis and a new Resources entry linking to Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision updated: v3.5.0 added. Revision removed: v3.4.3.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 was added and the notice about government funding/operating status (previously v3.4.1) was removed. These are maintenance/UI updates rather than changes to trial data or eligibility.SummaryDifference0.5%

- Check78 days agoChange DetectedAdded a site-wide notice about funding-related status and updated the page revision to v3.4.1, while removing the previous v3.4.0 revision.SummaryDifference0.5%

Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.